SCHEMBL38776

SCHEMBL38776

CC(C)=CCC/C(C)=C/C=C/C(C)=C/C=C/C(C)=C/C=C/C=C(C=O)\C=C\C=C(C)\C=C\C=C(/C)CCCC(C)(C)O

nearest known ligand 0.58

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
NR1I2 O75469 1/20 0.58
LMNA P02545 1/20 0.58
PGR P06401 1/20 0.58
ALDH1A1 P00352 1/20 0.39
FNTA P49354 2/20 0.36
FNTB P49356 2/20 0.36
ALOX15 P16050 2/20 0.34
SQLE Q14534 3/20 0.32
POLB P06746 1/20 0.32
KMT2A Q03164 1/20 0.30
KDM4E B2RXH2 1/20 0.30
ATM Q13315 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2837988 1.00 NR1I2 (0.58) NR1I2LMNAPGRALDH1A1FNTA
SCHEMBL116153 0.90 NR1I2 (0.71) NR1I2LMNAPGRALDH1A1FNTA
SCHEMBL116152 0.90 NR1I2 (0.71) NR1I2LMNAPGRALDH1A1FNTA
SCHEMBL2836407 0.88 NR1I2 (0.68) NR1I2LMNAPGRALDH1A1FNTA
SCHEMBL2832876 0.88 NR1I2 (0.68) NR1I2LMNAPGRALDH1A1FNTA
SCHEMBL2834686 0.88 NR1I2 (0.68) NR1I2LMNAPGRALDH1A1FNTA
SCHEMBL2836836 0.88 NR1I2 (0.68) NR1I2LMNAPGRALDH1A1FNTA
SCHEMBL2833805 0.88 NR1I2 (0.68) NR1I2LMNAPGRALDH1A1FNTA
SCHEMBL2831358 0.88 NR1I2 (0.54) NR1I2LMNAPGRALDH1A1FNTA
SCHEMBL29885033 0.88 NR1I2 (0.76) NR1I2LMNAPGRALDH1A1FNTA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 193 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013144595-A1 PERIDININ-CHLOROPHYLL BINDING PROTEINS PROTEIN TECHNOLOGIES LIMITED (GB) 2013-10-03 WO claimed
US-20260144834-A1 ANTIMICROBIAL FEED ADDITIVE Axitan Ltd. (GB) 2026-05-28 US disclosed
US-20260123660-A1 Particles Containing a Lipid Matrix Core and Active Ingredient LONZA SALES AG (CH) 2026-05-07 US disclosed
EP-4054348-B1 PARTICLES CONTAINING A LIPID MATRIX CORE AND ACTIVE INGREDIENT LONZA SALES AG (CH) 2026-01-28 EP disclosed
US-12471609-B2 Reducing the risk of viral infection due to viral contaminated feed NOVUS INTERNATIONAL, INC. (US) 2025-11-18 US disclosed
US-12465075-B2 Particles containing a lipid matrix core and active ingredient LONZA SALES AG (CH) 2025-11-11 US disclosed
EP-4642253-A1 USE OF MICROALGAE AND MICROALGAE DERIVED COMPONENTS IN CULTIVATED FOOD PRODUCTION Weforesea Ltd. (IL) 2025-11-05 EP disclosed
US-20250281440-A1 METHOD TO IMPROVE GROWTH PERFORMANCE, LIVABILITY, CARCASS CHARACTERISTICS AND/OR MILK QUALITY IN SWINE NUTRIQUEST, LLC 2025-09-11 US disclosed
US-12349704-B2 High quality cultured meat, compositions and methods for producing same ALEPH FARMS LTD. (IL) 2025-07-08 US disclosed
US-12310386-B2 Reducing the risk of viral infection due to viral contaminated feed NOVUS INTERNATIONAL, INC. (US) 2025-05-27 US disclosed
WO-2011161105-A2 HERBICIDAL COMPOSITIONS BASF SE (DE) 2011-12-29 WO disclosed
US-20110059164-A1 ENCAPSULATION OF OXIDATIVELY UNSTABLE COMPOUNDS AVEKA, INC. 2011-03-10 US disclosed
US-20110052680-A1 ENCAPSULATION OF OXIDATIVELY UNSTABLE COMPOUNDS AVERA, Inc. 2011-03-03 US disclosed
US-20110020519-A1 ENCAPSULATION OF OXIDATIVELY UNSTABLE COMPOUNDS AVEKA, INC. 2011-01-27 US disclosed
WO-2009089115-A1 ENCAPSULATION OF OXIDATIVELY UNSTABLE COMPOUNDS HORMEL FOODS CORPORATION (US) 2009-07-16 WO disclosed
WO-2009089117-A1 ENCAPSULATION OF OXIDATIVELY UNSTABLE COMPOUNDS HORMEL FOODS CORPORATION (US) 2009-07-16 WO disclosed
US-20080058400-A1 Skin external preparation FUJIFILM CORPORATION 2008-03-06 US disclosed
EP-1660596-A1 MICROORGANISM COATING COMPONENTS, COATINGS, AND COATED SURFACES McDaniel, Steven C. (US) 2006-05-31 EP disclosed
WO-2005026269-A1 MICROORGANISM COATING COMPONENTS, COATINGS, AND COATED SURFACES MCDANIEL C STEVEN (US) 2005-03-24 WO disclosed
US-20040175407-A1 Microorganism coating components, coatings, and coated surfaces REACTIVE SURFACES, LTD. 2004-09-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260144834-A1 ANTIMICROBIAL FEED ADDITIVE ELOVL6, CROCC, ELOC NR1I2 1086/4885LMNA 2049/4885PGR 4682/4885
US-20250281440-A1 METHOD TO IMPROVE GROWTH PERFORMANCE, LIVABILITY, CARCASS CHARACTERISTICS AND/OR MILK QUALITY IN SWINE PIGS, GLO1, IGFBP6 NR1I2 4701/4885LMNA 1769/4885PGR 2217/4885
US-20260123660-A1 Particles Containing a Lipid Matrix Core and Active Ingredient AUP1, MGLL, MBOAT4 NR1I2 2608/4885LMNA 1876/4885PGR 859/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.